Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience - Quiz - MDSpire

Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience

  • By

  • Elias Jabbour

  • Fausto Castagnetti

  • Mouna Bardey-Kanaan

  • Romuald Soichez

  • Nhan Thanh Nguyen

  • Deborah Kelly

  • Federica Rizzo

  • Petros Patos

  • Valentín García-Gutiérrez

  • July 18, 2026

Share

Original Source(s)

Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience

  • by Elias Jabbour, Fausto Castagnetti, Mouna Bardey-Kanaan, Romuald Soichez, Nhan Thanh Nguyen, Deborah Kelly, Federica Rizzo, Petros Patos, Valentín García-Gutiérrez

  • July 18, 2026

Related Content

Commentary: Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy

National trends in bone-metastatic prostate cancer mortality in the United States, 1999–2024: a multiple-cause-of-death analysis with projections to 2040

Radiomics and clinical data predict pseudoprogression after radiotherapy in high-grade glioma